Latest news with #JulianMegias
Business Insider
13-07-2025
- Business
- Business Insider
Kepler Capital Sticks to Its Buy Rating for Neinor Homes (0RNU)
In a report released on July 11, Julian Megias from Kepler Capital maintained a Buy rating on Neinor Homes, with a price target of €19.20. The company's shares closed last Friday at €17.24. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Megias is ranked #3461 out of 9820 analysts. Neinor Homes has an analyst consensus of Moderate Buy, with a price target consensus of €18.07. The company has a one-year high of €17.90 and a one-year low of €12.00. Currently, Neinor Homes has an average volume of 2,044.
Business Insider
25-06-2025
- Business
- Business Insider
Kepler Capital Reaffirms Their Buy Rating on Neinor Homes (0RNU)
Kepler Capital analyst Julian Megias maintained a Buy rating on Neinor Homes (0RNU – Research Report) on June 23 and set a price target of €19.00. The company's shares closed last Monday at €16.52. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Megias is a 3-star analyst with an average return of 9.1% and a 70.00% success rate. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Neinor Homes with a €17.24 average price target. The company has a one-year high of €17.90 and a one-year low of €12.00. Currently, Neinor Homes has an average volume of 1,998.
Business Insider
19-06-2025
- Business
- Business Insider
Kepler Capital Keeps Their Buy Rating on Neinor Homes (0RNU)
In a report released on June 17, Julian Megias from Kepler Capital maintained a Buy rating on Neinor Homes (0RNU – Research Report), with a price target of €16.10. The company's shares closed last Tuesday at €15.72. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Megias is a 3-star analyst with an average return of 7.1% and a 70.00% success rate. Neinor Homes has an analyst consensus of Moderate Buy, with a price target consensus of €16.55. Based on Neinor Homes' latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of €85.18 million and a net profit of €4.86 million. In comparison, last year the company had a net profit of €0
Business Insider
14-06-2025
- Business
- Business Insider
Kepler Capital Remains a Buy on Sonae SGPS (0ML0)
Kepler Capital analyst Julian Megias maintained a Buy rating on Sonae SGPS (0ML0 – Research Report) on June 12 and set a price target of €1.50. The company's shares closed last Thursday at €1.20. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Megias is a 2-star analyst with an average return of 2.3% and a 66.67% success rate. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sonae SGPS with a €1.50 average price target. Based on Sonae SGPS' latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of €2.98 billion and a net profit of €73.39 million. In comparison, last year the company earned a revenue of €2.36 billion and had a net profit of €222.1 million
Business Insider
12-06-2025
- Business
- Business Insider
Kepler Capital Sticks to Their Buy Rating for Atrys Health SA (A2T)
Kepler Capital analyst Julian Megias maintained a Buy rating on Atrys Health SA (A2T – Research Report) on June 10 and set a price target of €5.00. The company's shares closed last Tuesday at €2.57. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Megias is a 2-star analyst with an average return of 2.4% and a 62.50% success rate. Currently, the analyst consensus on Atrys Health SA is a Moderate Buy with an average price target of €5.00. The company has a one-year high of €4.08 and a one-year low of €2.28. Currently, Atrys Health SA has an average volume of 723.
